CVS HEALTH Corp (CVS)
Retail-Drug Stores and Proprietary Stores
Latest Price
$95.55
TTM P/E
25.21
Normalized P/E
22.28
Div Yield
2.78%
Book Value
62.32
P/B Ratio
1.53
Valuation metrics
adjust assumptions →EPS: $1.39
Book value / share: $59.18
Formula: √(22.5 × EPS × BVPS)
Graham Number
$43.02
55% downside
Norm. op. income: $12.0B (median of 7yr)
Tax rate: 25%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$31.23
67% downside
Base FCF: $10.4B (median of recent 5yr)
Growth: 1%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$67.29
30% downside
EPS: $1.39
Target P/E: 22×
Formula: EPS × P/E
P/E Fair Value
$30.58
68% downside
Institutional Ownership
90.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 123.22M | $12.75B | 9.64% | -2.70M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 83.32M | $8.62B | 6.52% | +665.3K | 2026-06-30 |
| Capital World Investors | 74.95M | $7.75B | 5.86% | -2.30M | 2026-06-30 |
| STATE STREET CORP | 60.28M | $6.24B | 4.72% | +961.2K | 2026-06-30 |
| Dodge & Cox | 50.01M | $5.17B | 3.91% | -1.77M | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 33.80M | $3.50B | 2.64% | +11.23M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 29.90M | $3.08B | 2.34% | +440.6K | 2026-06-30 |
| FMR LLC | 28.92M | $2.99B | 2.26% | -2.28M | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 26.64M | $2.75B | 2.08% | +639.9K | 2026-06-30 |
| Capital Research Global Investors | 24.33M | $2.52B | 1.90% | +4.32M | 2026-06-30 |